13F reference period
Q2 2026
Security Snapshot
VSEE HEALTH, INC. - Common Stock, par value $0.0001 per share (VSEE) Institutional Ownership
CUSIP: 92919Y102
13F Institutional Holders and Ownership History from Q3 2024 to Q3 2026
Institutions Reporting
19
Shares (Excl. Options)
6.64M
Full value: 6,640,778 · shares · 30 Jun 2026Price
$0.12
The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.
Save this security page for your next review
Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock, par value $0.0001 per share
- Symbol
- VSEE on OTC
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 6,640,778
- Total 13F value
- $767,821
- Portfolio coverage rank
- 0%
- Share change
- +2,213,865
- Value change
- +$255,636
- Number of holders
- 19
- Shares outstanding
- 55,649,782
- SEC-reported price per share
- $0.02
- Insider filing price
- $0.02
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
3 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source
Key facts
- VSEE - VSEE HEALTH, INC. - Common Stock, par value $0.0001 per share is tracked under CUSIP 92919Y102.
- 19 institutions reported positions in Q2 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 12 to 19 between Q1 2026 and Q2 2026.
- SEC-reported value moved from to
$1.11M
Full value: $1,108,500 · USD · 31 Mar 2026.$767.82K
Full value: $767,821 · USD · 30 Jun 2026
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 19 institutions filings for Q2 2026.
Security key
92919Y102
13F reference period
Q2 2026
13F holders
19
13D/G owners
4
CIK / CUSIP context first
Open Q2 2026 holders
VSEE full holder history
VSEE HEALTH, INC. SEC filings
VSEE HEALTH, INC. company facts
VSEE HEALTH, INC. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 92919Y102:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
VSEE
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 7.3% | -27% | $471,547 | -$90,430 | 4,079,129 | -16% | Armistice Capital, LLC | 30 Jun 2026 |
| Dominion Capital LLC | 3% | -69% | $379,886 | -$300,170 | 1,014,654 | -44% | Dominion Capital LLC | 31 Dec 2025 |
| Sands Lawrence M. | 2.9% | $721,125 | 961,500 | LAWRENCE SANDS | 21 Jul 2025 | |||
| Alta Partners LLC | 2% | -75% | $308,332 | -$511,064 | 833,331 | -62% | Alta Partners, LLC | 31 Dec 2025 |
As of 30 Jun 2026,
19
institutional investors reported holding
shares of
VSEE HEALTH, INC. - Common Stock, par value $0.0001 per share (VSEE).
This represents
12%
of the company’s total
outstanding shares.
6.64M
Full value: 6,640,778 · shares · 30 Jun 202655.65M
Full value: 55,649,782 · shares · Stored outstanding share count13F concentration
Top 19 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
12%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 7.3% | 4,079,129 | +17% | 0.01% | $471,547 |
| JANE STREET GROUP, LLC | 1.4% | 785,322 | 0% | $90,783 | |
| VANGUARD FIDUCIARY TRUST CO | 0.64% | 354,298 | +16220% | 0% | $41,099 |
| HRT FINANCIAL LP | 0.57% | 317,924 | 0% | $36,000 | |
| VANGUARD CAPITAL MANAGEMENT LLC | 0.38% | 213,716 | 0% | 0% | $24,791 |
| GEODE CAPITAL MANAGEMENT, LLC | 0.37% | 207,081 | -53% | 0% | $23,938 |
| Cygnus Capital Advisors, LLC | 0.26% | 142,908 | +19% | 0.01% | $17,000 |
| XTX Topco Ltd | 0.23% | 129,160 | +143% | 0% | $14,931 |
| Virtu Financial LLC | 0.19% | 105,998 | +263% | 0% | $12,000 |
| OSAIC HOLDINGS, INC. | 0.18% | 99,785 | 0% | $11,974 | |
| TWO SIGMA SECURITIES, LLC | 0.13% | 73,029 | 0% | $8,442 | |
| CITADEL ADVISORS LLC | 0.06% | 33,557 | 0% | $3,879 | |
| NORTHERN TRUST CORP | 0.05% | 27,373 | 0% | $3,164 | |
| STATE STREET CORP | 0.03% | 18,900 | 0% | 0% | $2,185 |
| UBS Group AG | 0.03% | 18,022 | -49% | 0% | $2,091 |
| GOLDMAN SACHS GROUP INC | 0.03% | 14,932 | 0% | $1,726 | |
| Wealthcare Advisory Partners LLC | 0.03% | 14,098 | 0% | 0% | $1,630 |
| Tower Research Capital LLC (TRC) | 0.01% | 4,020 | -13% | 0% | $465 |
| BARCLAYS PLC | 0% | 1,526 | 0% | $176 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
9
Headline period
Q2 2026
Rows shown
1-9 of 9
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q3 | 0 | $0 | -$1,630 | $0.02 | 0 |
| 2026 Q2 | 6,640,778 | $767,821 | +$255,636 | $0.12 | 19 |
| 2026 Q1 | 4,435,229 | $1,108,500 | +$705,169 | $0.25 | 12 |
| 2025 Q4 | 1,020,791 | $381,839 | +$64,999 | $0.37 | 16 |
| 2025 Q3 | 823,422 | $504,345 | +$358,702 | $0.61 | 13 |
| 2025 Q2 | 230,014 | $266,814 | -$750,742 | $1.16 | 11 |
| 2025 Q1 | 855,885 | $1,027,060 | +$771,734 | $1.20 | 11 |
| 2024 Q4 | 208,419 | $283,449 | +$173,491 | $1.36 | 10 |
| 2024 Q3 | 79,502 | $118,457 | +$118,457 | $1.49 | 5 |